Inke S.A: APIs manufacturing plant.
01 1Inke SA
02 1Glaxo Operations UK Ltd
03 1Glaxo Wellcome Manufacturing Pte. Ltd
04 1MSN Laboratories Private Limited
05 2STERLING SPA
06 2Sterling Chemical Malta Ltd
07 1TAPI Czech Industries s.r.o.
08 1Teva Czech Industries s.r.o
01 5VILANTEROL TRIFENATATE
02 3Vilanterol Trifenatate
03 2vilanterol trifenatate
01 1India
02 1Israel
03 2Italy
04 2Malta
05 1Spain
06 2United Kingdom
07 1Blank
Inke S.A: APIs manufacturing plant.
NDC Package Code : 64567-0027
Start Marketing Date : 2021-01-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52482-009
Start Marketing Date : 2014-06-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63379-114
Start Marketing Date : 2024-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0095
Start Marketing Date : 2019-10-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59057-016
Start Marketing Date : 2023-05-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59057-017
Start Marketing Date : 2023-05-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64918-1919
Start Marketing Date : 2022-01-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64918-1921
Start Marketing Date : 2022-06-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47848-054
Start Marketing Date : 2016-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84644-054
Start Marketing Date : 2024-11-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Vilanterol Trifenatate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vilanterol Trifenatate, including repackagers and relabelers. The FDA regulates Vilanterol Trifenatate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vilanterol Trifenatate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vilanterol Trifenatate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vilanterol Trifenatate supplier is an individual or a company that provides Vilanterol Trifenatate active pharmaceutical ingredient (API) or Vilanterol Trifenatate finished formulations upon request. The Vilanterol Trifenatate suppliers may include Vilanterol Trifenatate API manufacturers, exporters, distributors and traders.
click here to find a list of Vilanterol Trifenatate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vilanterol Trifenatate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vilanterol Trifenatate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vilanterol Trifenatate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vilanterol Trifenatate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vilanterol Trifenatate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vilanterol Trifenatate suppliers with NDC on PharmaCompass.
We have 6 companies offering Vilanterol Trifenatate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
